In the BioHarmony Drug Report Database

"Preview" Icon

Cilostazol

Pletal (cilostazol) is a small molecule pharmaceutical. Cilostazol was first approved as Pletal on 1999-01-15. It is used to treat intermittent claudication, peripheral vascular diseases, and vascular graft occlusion in the USA. The pharmaceutical is active against cGMP-inhibited 3′,5′-cyclic phosphodiesterase B. In addition, it is known to target cGMP-inhibited 3′,5′-cyclic phosphodiesterase A.

 

Trade Name

 

Pletal
 

Common Name

 

cilostazol
 

ChEMBL ID

 

CHEMBL799
 

Indication

 

intermittent claudication, peripheral vascular diseases, vascular graft occlusion
 

Drug Class

 

Image (chem structure or protein)

Cilostazol structure rendering